Chronic systemic inflammation in FMF leads to elevated proinflammatory cytokines (IL-1β, TNF-α, IL-6) which drive hepatic inflammation, insulin resistance, and NF-κB activation. This evidence concerns the gene IL1B and Insulin resistance.